Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-06 Sale |
2025-02-06 8:06 pm |
Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:59 pm |
Revance Therapeutics Inc. | RVNC | Foley Mark J President & CEO |
112,619 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:59 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
124,438 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:58 pm |
Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC |
114,104 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:58 pm |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
95,212 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:57 pm |
Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer |
107,942 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:56 pm |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:56 pm |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:49 pm |
Revance Therapeutics Inc. | RVNC | Coric Vlad Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:49 pm |
Revance Therapeutics Inc. | RVNC | Beraud Jill Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:48 pm |
Revance Therapeutics Inc. | RVNC | Nolet Chris Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
| 2025-02-06 Sale |
2025-02-06 3:45 pm |
Revance Therapeutics Inc. | RVNC | Russell Angus C. Director |
15,000 | $0 | $0 | 0 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 4:31 pm |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
3,908 | $4.17 | $16,296 | 104,945 (Direct) |
View |
| 2024-04-16 Sale |
2024-04-17 4:34 pm |
Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer |
2,392 | $3.8028 | $9,096 | 114,864 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 6:45 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
9,211 | $5.0425 | $46,446 | 167,550 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 6:44 pm |
Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC |
8,125 | $5.0426 | $40,971 | 137,815 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 6:44 pm |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
9,361 | $5.0426 | $47,204 | 192,666 (Direct) |
View |
| 2024-03-06 Purchase |
2024-03-08 4:33 pm |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
30,000 | $6.98 | $209,400 | 1,126,381 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-04 Equity Swap |
2025-02-06 8:06 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director |
30,106 | $3.65 | 0 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-06 3:59 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J President & CEO |
84,686 | $0 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:59 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J President & CEO |
1,107,848 | $3.65 | 0 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-06 3:59 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
20,883 | $0 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:59 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
97,999 | $3.65 | 0 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-06 3:58 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC |
18,125 | $0 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:58 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC |
47,815 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:58 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
9,733 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:57 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer |
6,922 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:56 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
16,675 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:56 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
16,561 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:49 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Coric Vlad Director |
5,784 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:49 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Beraud Jill Director |
28,606 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:48 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Nolet Chris Director |
28,606 | $3.65 | 0 (Direct) |
View |
| 2025-02-04 Equity Swap |
2025-02-06 3:45 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Russell Angus C. Director |
36,506 | $3.65 | 0 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 7:53 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
27,933 | $0 | 1,135,781 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 7:53 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
6,888 | $0 | 201,554 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 7:53 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC |
5,979 | $0 | 143,794 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-03 4:34 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
1,000 | $2.1845 | 194,666 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-03 4:33 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
1,000 | $2.1845 | 1,107,848 (Direct) |
View |
| 2024-06-30 Option Award |
2024-07-02 5:47 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
1,000 | $2.1845 | 1,106,848 (Direct) |
View |
| 2024-06-30 Option Award |
2024-07-02 5:47 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
1,000 | $2.1845 | 193,666 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 08:47 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Ware Olivia C Director |
38,458 | $0 | 55,133 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 08:47 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Russell Angus C. Director |
38,458 | $0 | 74,964 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 08:46 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Nolet Chris Director |
38,458 | $0 | 67,064 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 08:45 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Kolaja Carey OConnor Director |
38,458 | $0 | 55,019 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 08:44 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director |
38,458 | $0 | 68,564 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 08:43 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Coric Vlad Director |
38,458 | $0 | 44,242 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 08:42 am |
N/A 2034-04-30 |
Revance Therapeutics Inc. | RVNC | Beraud Jill Director |
38,458 | $0 | 67,064 (Direct) |
View |
| 2024-03-15 Tax Withholding |
2024-03-19 6:45 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,967 | $5.305 | 167,550 (Direct) |
View |
| 2024-03-15 Tax Withholding |
2024-03-19 6:44 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC |
3,269 | $5.305 | 137,815 (Direct) |
View |
| 2024-03-15 Tax Withholding |
2024-03-19 6:44 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
3,822 | $5.305 | 192,666 (Direct) |
View |
| 2024-03-15 Tax Withholding |
2024-03-19 6:43 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
20,533 | $5.305 | 1,105,848 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 5:34 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
22,110 | $0 | 179,728 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 5:33 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Moxie Dwight CLO & GC |
15,143 | $0 | 149,209 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 4:44 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Schilke Tobin CFO |
17,447 | $0 | 205,849 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 4:33 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Foley Mark J CEO |
70,750 | $0 | 1,096,381 (Direct) |
View |
Ownership |
2024-02-29 4:36 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Jordan Erica Chief Commercial Officer |
0 | $0 | 237,256 (Direct) |
View |
Ownership |
2024-02-29 4:32 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Hollander David CMO & Global Therapeutics Lead |
0 | $0 | 278,522 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:48 pm |
2025-02-15 2028-01-31 |
Revance Therapeutics Inc. | RVNC | Moxie Dwight SVP, GC & Secretary |
225,000 | $0 | 269,066 (Direct) |
View |